Germline TP53 mutations and Li-Fraumeni syndrome
- PMID: 12619118
- DOI: 10.1002/humu.10185
Germline TP53 mutations and Li-Fraumeni syndrome
Erratum in
- Hum Mutat. 2003 May;21(5):551
Abstract
There are now reports of nearly 250 independent germline TP53 (p53) mutations in over 100 publications. Such mutations are typically associated with Li-Fraumeni or Li-Fraumeni-like syndrome, although many have been identified in cohorts of patients with tumors considered to be typical of LFS. In general, the spectrum of mutations that has been detected in the germline reflects that found in tumors, although there are some notable exceptions in certain tumor types. Detailed knowledge of the pedigrees allows a comprehensive analysis of genotype-phenotype correlations and an understanding of the tumors that are associated with germline TP53 mutations. This review will discuss the spectrum of mutations and the methods for mutation detection, the tumors associated with inheritance of a germline mutation, and some of the ethical and clinical problems in patients with a germline TP53 mutation.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429. J Med Genet. 2010. PMID: 20522432
-
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.Oncogene. 1998 Sep 3;17(9):1061-8. doi: 10.1038/sj.onc.1202033. Oncogene. 1998. PMID: 9764816
-
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Curr Opin Oncol. 2010. PMID: 19952748 Review.
-
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21. Cancer Lett. 2007. PMID: 16494995
-
[Germline mutations of the p53 gene].Pathol Biol (Paris). 1997 Dec;45(10):845-51. Pathol Biol (Paris). 1997. PMID: 9769948 Review. French.
Cited by
-
P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells.Am J Cancer Res. 2015 Dec 15;6(1):114-25. eCollection 2016. Am J Cancer Res. 2015. PMID: 27073729 Free PMC article.
-
Structural basis for ASPP2 recognition by the tumor suppressor p73.J Mol Biol. 2012 Nov 2;423(4):515-27. doi: 10.1016/j.jmb.2012.08.005. Epub 2012 Aug 20. J Mol Biol. 2012. PMID: 22917970 Free PMC article.
-
Joint effects of genomic markers and urinary methylation capacity associated with inorganic arsenic metabolism on the occurrence of cancers among residents in arseniasis-endemic areas: A cohort subset with average fifteen-year follow-up.Biomed J. 2021 Dec;44(6 Suppl 2):S218-S225. doi: 10.1016/j.bj.2020.10.005. Epub 2020 Oct 13. Biomed J. 2021. PMID: 35297370 Free PMC article.
-
p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.J Cell Biol. 2006 Jan 2;172(1):115-25. doi: 10.1083/jcb.200507106. Epub 2005 Dec 27. J Cell Biol. 2006. PMID: 16380437 Free PMC article.
-
Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis.Childs Nerv Syst. 2014 Jan;30(1):147-54. doi: 10.1007/s00381-013-2307-1. Epub 2013 Oct 27. Childs Nerv Syst. 2014. PMID: 24162619
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
